公开(公告)号：US20150283251A1

公开(公告)日：2015-10-08

申请号：US14437626

申请日：2013-11-26

Applicant: AMOREPACIFIC CORPORATION

Inventor： Jeong Ah Hwang ,  Yu Jin Oh ,  Young Kyung Kim ,  Jin Oh Chung ,  Sang Jun Lee ,  Soon Mi Shim ,  Jae Hwan Chung

IPC: A61K47/40 ,  A61K9/14 ,  A61K9/20 ,  A61K31/353

CPC classification number: A61K47/40 ,  A23L29/35 ,  A23L33/105 ,  A61K9/009 ,  A61K9/0095 ,  A61K9/1652 ,  A61K9/2059 ,  A61K31/00 ,  A61K31/185 ,  A61K31/194 ,  A61K31/353 ,  A61K36/82 ,  A61K47/6951

Abstract: Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.

Abstract translation: 公开了一种儿茶素生物利用度增强剂，其包含环糊精作为活性成分。 此外，公开了包含儿茶素生物利用度增强剂（包括儿茶素和环糊精）的组合物。 本说明书中公开的组合物可以改善儿茶素的稳定性，其具有显着低的肠吸收速率，从而可以提高儿茶素的生物可接近性，肠输送速率和生物利用度。 因此，改善的生物利用度可以进一步增加儿茶素的作用，例如减轻体重和体脂肪的作用，抗氧化作用和抗衰老作用。 具有上述特征的本说明书中公开的组合物可以有效地用于食品或制药领域。

公开(公告)号：US10314915B2

公开(公告)日：2019-06-11

申请号：US14437626

申请日：2013-11-26

Applicant: AMOREPACIFIC CORPORATION

Inventor： Jeong Ah Hwang ,  Yu Jin Oh ,  Young Kyung Kim ,  Jin Oh Chung ,  Sang Jun Lee ,  Soon Mi Shim ,  Jae Hwan Chung

IPC: A61K31/047 ,  A61K31/375 ,  A61K9/00 ,  A61K9/16 ,  A61K9/20 ,  A23L29/30 ,  A61K31/00 ,  A61K36/82 ,  A61K47/40 ,  A61K47/69 ,  A23L33/105 ,  A61K31/185 ,  A61K31/194 ,  A61K31/353

Abstract: Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.